40 participants
Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-12-13
- Start Date:
- 2019-01-31
- Completion:
- 2020-12-31
Conditions
- Donor Lymphocyte Infusion
- Peripheral Blood Stem Cell Transplantation
- Relapse
- Graft-versus-host Disease
- Decitabine
Interventions
- BIOLOGICAL
No Results Yet